Cargando…
Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067793/ http://dx.doi.org/10.4103/2230-8210.342224 |
Sumario: | Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score retrospectively and determine its usefulness in the management of our PA patients. Results: Sixteen patients were included in the study (56.3% males) with mean age of 34.25 years. Presenting feature was headache in 87.5%, visual disturbance in 50%, seizures in 18.8% and focal deficit in 6.3%. The precipitating event was found in 3 (18.9%). The mean PAS in conservatively managed patients was 0.27 and in those surgically managed was 3.2. Emergent pituitary surgery was performed in 5 patients (31.3%) of which 4 had PAS of >3. Conclusion: Clinical severity based on PAS ≥ 3 appeared to influence the management towards emergency surgical intervention and can be a useful tool to monitor conservatively managed patients and intervene. |
---|